As Asia continues to attract an increasing number of clinical trials, project sponsors need to take into consideration the specific laws and regulations of each country where the trials take place. This article highlights the different processes in place in China, Thailand, and Vietnam, as well as the importance of the agreements signed between the parties from the perspective of intellectual property law and drug importation.